Security key
760273102
Repare Therapeutics Inc. - Common shares, no par value (RPTX)
CUSIP: 760273102
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common shares, no par value
- Shares outstanding
- 42,837,925
- Total 13F shares
- 36,251,577
- Share change
- +464,148
- Total reported value
- $437,732,348
- Put/Call ratio
- 6.3%
- Price per share
- $12.08
- Number of holders
- 75
- Value change
- +$5,862,256
- Number of buys
- 32
- Number of sells
- 31
Report period
Q3 2023
Institutions
75
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 760273102
Recent filing periods:
Top shareholders of RPTX - Repare Therapeutics Inc. - Common shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q3 2023
As of 30 Sep 2023,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,251,577 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, Deep Track Capital, LP, CHI Advisors LLC, Versant Venture Management, LLC, ARK Investment Management LLC, Redmile Group, LLC, MPM ASSET MANAGEMENT LLC, T. Rowe Price Investment Management, Inc., and MPM BIOIMPACT LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
77
Q3 2023 holders
75
Holder diff
-2
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.